XML 33 R16.htm IDEA: XBRL DOCUMENT v3.25.4
Income Taxes
 12 Months Ended
Sep. 30, 2025
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
The components of income (loss) before income tax provision are as follows:
 Years Ended 
 September 30,
 20252024
U.S.$(1,369)$(8,309)
Non-U.S.621 (280)
Loss before income tax provision$(748)$(8,589)
Income tax provision consists of the following:
 Years Ended
September 30,
 20252024
Current income tax provision (benefit):
U.S. federal$— $70 
U.S. state and local9 1 
Non-U.S.167 (46)
Total current tax provision 176 25 
Deferred income tax provision:
U.S. federal9 10 
U.S. state and local— 2 
Total deferred tax provision9 12 
Income tax provision$185 $37 
The income tax provision in the accompanying consolidated statements of operations differs from amounts determined by using the statutory rate as follows:
 Years Ended
September 30,
 20252024
Loss before income tax provision$(748)$(8,589)
Income tax provision (benefit) at U.S. federal statutory rates(157)(1,804)
Tax effect of:
Foreign rate differential150 (4)
Permanent items(2)59 
State and local income taxes9 4 
Federal tax credits(226)(241)
Valuation allowance400 1,943 
Other11 80 
Income tax provision$185 $37 
Deferred tax assets and liabilities at September 30 consist of the following:
20252024
Deferred tax assets:
Net U.S. operating loss carryforwards$8,369 $9,407 
Net non-U.S. operating loss carryforwards639 629 
Employee benefits324 849 
Inventory reserves546 — 
Allowance for credit losses36 28
Intangibles— 296 
Foreign tax credits1,215 1,724 
Other tax credits2,227 2,175 
Other 2,211 1,908 
Total deferred tax assets$15,567 $17,016 
Deferred tax liabilities:
Depreciation(4,307)(5,308)
Inventory reserves— (573)
Prepaid expenses(517)(338)
Intangibles(245)— 
Other(9)(51)
Total deferred tax liabilities$(5,078)$(6,270)
Net deferred tax assets 10,489 10,746 
Valuation allowance(10,652)(10,900)
Net deferred tax liabilities$(163)$(154)
At September 30, 2025, the Company has a non-U.S. tax loss carryforward of approximately $5,458 related to the Company’s non-operating subsidiary. The Company’s non-operating subsidiary ceased operations in 2007 and therefore, a valuation allowance has been recorded against the deferred tax asset related to the Irish tax loss carryforward because it is unlikely that such operating loss can be utilized unless the Irish subsidiary resumes operations. The non-operating and Italian tax loss carryforwards do not expire.
The Company has $1,215 of foreign tax credit carryforwards that are subject to expiration in fiscal 2026-2028, $2,215 of U.S. general business tax credits that are subject to expiration in 2035-2045, $2,248 of interest expense carryforward that do not expire, $670 of capital loss carryforward that expires in 2030, and $32,943 of U.S. Federal tax loss carryforwards with $4,643 subject to expiration in fiscal 2037 and $28,300 that do not expire. A valuation allowance has been recorded against the deferred tax assets related to the foreign tax credit carryforwards, U.S. general business credits, interest expense carryforward, and U.S. Federal tax loss carryforwards. The valuation allowance decreased during fiscal 2025 related to $116 in amounts charged to expense less $364 of reductions charged to other accounts. The valuation allowance increased during fiscal 2024 related to $2,000 in amounts charged to expense less $212 of reductions charged to other accounts.
In addition, the Company has $12 of U.S. state tax credit carryforwards subject to expiration in fiscal 2029 and $30,151 of U.S. state and local tax loss carryforwards subject to expiration in fiscal 2026-2044. The U.S. state tax credit carryforwards and U.S. state and local tax loss carryforwards have been fully offset by a valuation allowance.
The Company reported liabilities for uncertain tax positions, excluding any related interest and penalties, of $22 for both fiscal 2025 and 2024. If recognized, $22 of the fiscal 2025 uncertain tax positions would impact the effective tax rate. As of September 30, 2025, the Company had accrued interest of $19 and recognized $1 for interest and penalties in operations. The Company classifies interest and penalties on uncertain tax positions as income tax expense. A summary of activity related to the Company’s uncertain tax position is as follows:
20252024
Balance at beginning of year$22 $22 
Decrease due to lapse of statute of limitations— — 
Balance at end of year$22 $22 
The Company is subject to income taxes in the U.S. federal jurisdiction, Ireland, Italy and various states and local jurisdictions. The Company believes it has appropriate support for its federal income tax returns. The Company is no longer subject to U.S. federal income tax examinations by tax authorities for fiscal years prior to 2022, state and local income tax examinations for fiscal years prior to 2019, or non-U.S. income tax examinations by tax authorities for fiscal years prior to 2009.
The Company does not record deferred taxes on the undistributed earnings of its non-U.S. subsidiaries as it does not expect the temporary differences related to those unremitted earnings to reverse in the foreseeable future. In October 2024, the Company sold 100% of the share capital of CBlade for cash consideration. No material tax resulted from the sale. The only non-U.S subsidiaries the Company has are the two Ireland non-operating entities and as of September 30, 2025, the Company’s Ireland subsidiaries had accumulated deficits of approximately $2.